Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A
Clinical trial NCT02547714 · COMPLETED
Trial details
- NCT number
- NCT02547714
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-16
- Primary completion
- 2016-05-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.